Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micro-dose hCG in CC-resistant anovulatory PCOS
IRCT138805061141N3Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human chorionic gonadotropin in polycystic ovary syndrome (PCOS), anovulation, sponsored by Royan Institute. Started Jun 2009; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
polycystic ovary syndrome (PCOS)anovulation
Beyond the preview
Go deeper on IRCT138805061141N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138805061141N3.